標普和納斯達克內在價值 聯繫我們

Lifeline Biotechnologies, Inc. LLBO OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
17/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lifeline Biotechnologies, Inc. (LLBO) 是一家上市公司 屬於 醫療保健 板塊,經營於 Medical - Devices 產業. 公司總部位於 Reno, NV, 美国. 現任CEO為 James D. Holmes.

LLBO 擁有 IPO日期為 1995-02-02, 在 Other OTC, 市值為 $2.17M.

關於 Lifeline Biotechnologies, Inc.

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada.

📍 1325 Airmotive Way, Reno, NV 89502 📞 775-852-3222
公司詳情
所屬板塊醫療保健
細分行業Medical - Devices
國家美国
交易所Other OTC
貨幣USD
IPO日期1995-02-02
首席執行官James D. Holmes
交易資訊
當前價格$0.00
市値$2.17M
52週區間0.0001-0.0013
Beta-2.04
ETF
ADR
CUSIP53219E808
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值,發現被低估的股票。
每週線上課程
給我們留言